These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9790962)

  • 41. Molecular cloning, heterologous expression and functional characterization of a novel translationally-controlled tumor protein (TCTP) family member from Loxosceles intermedia (brown spider) venom.
    Sade YB; Bóia-Ferreira M; Gremski LH; da Silveira RB; Gremski W; Senff-Ribeiro A; Chaim OM; Veiga SS
    Int J Biochem Cell Biol; 2012 Jan; 44(1):170-7. PubMed ID: 22051631
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sex-linked variation of Loxosceles intermedia spider venoms.
    Cristina de Oliveira K; Gonçalves de Andrade RM; Giusti AL; Dias da Silva W; Tambourgi DV
    Toxicon; 1999 Jan; 37(1):217-21. PubMed ID: 9920493
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Brown spider (Loxosceles genus) venom toxins: Evaluation of biological conservation by immune cross-reactivity.
    Buch DR; Souza FN; Meissner GO; Morgon AM; Gremski LH; Ferrer VP; Trevisan-Silva D; Matsubara FH; Boia-Ferreira M; Sade YB; Chaves-Moreira D; Gremski W; Veiga SS; Chaim OM; Senff-Ribeiro A
    Toxicon; 2015 Dec; 108():154-66. PubMed ID: 26474948
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alternate complement pathway activation by recluse spider venom.
    Kurpiewski G; Campbell BJ; Forrester LJ; Barrett JT
    Int J Tissue React; 1981 Mar; 3(1):39-45. PubMed ID: 7287056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Study of anti-loxosceles serum action on hemolytic and ulcero-necrotic cutaneous effects of Loxosceles laeta venom].
    Bravo M; Oviedo I; Farías P; Schenone H
    Rev Med Chil; 1994 Jun; 122(6):625-9. PubMed ID: 7732205
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inactivation of complement by Loxosceles reclusa spider venom.
    Gebel HM; Finke JH; Elgert KD; Cambell BJ; Barrett JT
    Am J Trop Med Hyg; 1979 Jul; 28(4):756-62. PubMed ID: 464196
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tetracycline and penicillin resistant Clostridium perfringens isolated from the fangs and venom glands of Loxosceles laeta: its implications in loxoscelism treatment.
    Catalán A; Espoz MC; Cortés W; Sagua H; González J; Araya JE
    Toxicon; 2010 Nov; 56(6):890-6. PubMed ID: 20600224
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sphingomyelinase D from venoms of Loxosceles spiders: evolutionary insights from cDNA sequences and gene structure.
    Binford GJ; Cordes MH; Wells MA
    Toxicon; 2005 Apr; 45(5):547-60. PubMed ID: 15777950
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pattern of inflammatory response to Loxosceles intermedia venom in distinct mouse strains: a key element to understand skin lesions and dermonecrosis by poisoning.
    Ribeiro MF; Oliveira FL; Monteiro-Machado M; Cardoso PF; Guilarducci-Ferraz VV; Melo PA; Souza CM; Calil-Elias S
    Toxicon; 2015 Mar; 96():10-23. PubMed ID: 25600642
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ontogenetic development of Loxosceles intermedia spider venom.
    Gonçalves de Andrade RM; De Oliveira KC; Giusti AL; Dias da Silva W; Tambourgi DV
    Toxicon; 1999 Apr; 37(4):627-32. PubMed ID: 10082162
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Brown spider dermonecrotic toxin directly induces nephrotoxicity.
    Chaim OM; Sade YB; da Silveira RB; Toma L; Kalapothakis E; Chávez-Olórtegui C; Mangili OC; Gremski W; von Dietrich CP; Nader HB; Sanches Veiga S
    Toxicol Appl Pharmacol; 2006 Feb; 211(1):64-77. PubMed ID: 16005484
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyaluronidases in Loxosceles intermedia (Brown spider) venom are endo-beta-N-acetyl-d-hexosaminidases hydrolases.
    da Silveira RB; Chaim OM; Mangili OC; Gremski W; Dietrich CP; Nader HB; Veiga SS
    Toxicon; 2007 May; 49(6):758-68. PubMed ID: 17210169
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neutralization of dermonecrotic and lethal activities and differences among 32-35 kDa toxins of medically important Loxosceles spider venoms in Brazil revealed by monoclonal antibodies.
    Guilherme P; Fernandes I; Barbaro KC
    Toxicon; 2001 Sep; 39(9):1333-42. PubMed ID: 11384721
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Compared chemical properties of dermonecrotic and lethal toxins from spiders of the genus Loxosceles (Araneae).
    Barbaro KC; Sousa MV; Morhy L; Eickstedt VR; Mota I
    J Protein Chem; 1996 May; 15(4):337-43. PubMed ID: 8819009
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of a direct hemolytic effect dependent on the catalytic activity induced by phospholipase-D (dermonecrotic toxin) from brown spider venom.
    Chaves-Moreira D; Chaim OM; Sade YB; Paludo KS; Gremski LH; Donatti L; de Moura J; Mangili OC; Gremski W; da Silveira RB; Senff-Ribeiro A; Veiga SS
    J Cell Biochem; 2009 Jul; 107(4):655-66. PubMed ID: 19455508
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tetracycline protects against dermonecrosis induced by Loxosceles spider venom.
    Paixão-Cavalcante D; van den Berg CW; Gonçalves-de-Andrade RM; Fernandes-Pedrosa Mde F; Okamoto CK; Tambourgi DV
    J Invest Dermatol; 2007 Jun; 127(6):1410-8. PubMed ID: 17218940
    [TBL] [Abstract][Full Text] [Related]  

  • 57. North and South American Loxosceles spiders: development of a polyvalent antivenom with recombinant sphingomyelinases D as antigens.
    Olvera A; Ramos-Cerrillo B; Estévez J; Clement H; de Roodt A; Paniagua-Solís J; Vázquez H; Zavaleta A; Arruz MS; Stock RP; Alagón A
    Toxicon; 2006 Jul; 48(1):64-74. PubMed ID: 16759681
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression and immunological cross-reactivity of LALP3, a novel astacin-like metalloprotease from brown spider (Loxosceles intermedia) venom.
    Morgon AM; Belisario-Ferrari MR; Trevisan-Silva D; Meissner GO; Vuitika L; Marin B; Tashima AK; Gremski LH; Gremski W; Senff-Ribeiro A; Veiga SS; Chaim OM
    Biochimie; 2016; 128-129():8-19. PubMed ID: 27343628
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure of a novel class II phospholipase D: catalytic cleft is modified by a disulphide bridge.
    de Giuseppe PO; Ullah A; Silva DT; Gremski LH; Wille AC; Chaves Moreira D; Ribeiro AS; Chaim OM; Murakami MT; Veiga SS; Arni RK
    Biochem Biophys Res Commun; 2011 Jun; 409(4):622-7. PubMed ID: 21616057
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Milking and partial characterization of venom from the Brazilian spider Vitalius dubius (Theraphosidae).
    Rocha-E-Silva TA; Sutti R; Hyslop S
    Toxicon; 2009 Jan; 53(1):153-61. PubMed ID: 19032960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.